The first stop for professional medicines advice

Administering

53 results

Applied filters

Off label medicine use under a Patient Group Direction

10 June 2021This article explains the legislation and guidance on the use of PGDs when a medicine is to be used outside its licence ('off-label').

Choosing between oral vancomycin options

18 May 2021Local decision makers should choose between the options for giving vancomycin orally. Licensing status and other factors affect decision making.

Including medicines with Risk Minimisation Measures (RMM) in PGDs

16 March 2021Medicines with RMM may not be suitable for inclusion within Patient Group Directions (PGDs). If used, the RMM must be stated within the PGD.

Legal mechanisms and their application to give COVID-19 vaccines

7 January 2021A summary of the different legal mechanisms available, a priority order for the options, and advice on their application to different professional groups.

Administering

All our advice relating to administering medicines; ranging from legal mechanism frameworks through to practical administration.

Patient Group Directions (PGDs) and abortifacients

14 September 2020This article advises on the legal position on the supply/administration of abortifacients under PGDs.

Mixing of medicines and Patient Group Directions

9 September 2020This article provides advice on the legal considerations required when considering mixing medicines to be supplied or administered under a PGD

About SPS Cytotoxic Drug and Biopharmaceutical Stability monographs and advice

24 August 2020Validated stability data ensures products compounded by cytotoxic reconstitution processes within aseptic units are safe for patients

Patient Group Direction use in End of Life Care

10 August 2020Considerations required before implementing Patient Group Directions (PGDs) in End of Life Care.

Off-label or unlicensed product use under HMR 2012 exemptions

8 January 2020A legal position summary regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the Human Medicines Regulations 2012
admin